MDLinxMinimally Invasive Procedure Outperforms Drug Therapy for Advanced Atrial Fibrillation

A multicenter randomized trial in patients with persistent atrial fibrillation compared first-line pulsed field catheter ablation against antiarrhythmic drug therapy. Ablation produced better rhythm control at one year with comparable serious adverse event rates.

Clinical Considerations:

• Ablation patients were significantly more likely to remain free of abnormal rhythms at one year compared with the drug-therapy group.
• Serious adverse event rates were similar between groups, suggesting an acceptable safety profile in this higher-risk population.
• Findings extend prior first-line ablation evidence from early AFib into persistent disease, where stepwise drug-first approaches have dominated.
• Pulsed field ablation uses targeted electrical pulses rather than heat or cryothermal energy, offering a tissue-sparing mechanism.

Practice Applications:

• Consider earlier ablation referral for patients with persistent AFib.
• Integrate shared decision-making about first-line ablation versus antiarrhythmic therapy.
• Recognize persistent AFib patients as candidates for disease-modifying intervention.
• Monitor evolving society guidance as this evidence is incorporated.